Table of Contents _________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12981 AMETEK, Inc. (Exact name ...

Exhibit 99.1 AMETEK Announces Third Quarter Results Berwyn, Pa., October 31, 2024 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2024. AMETEK's third quarter 2024 sales were $1.71 billion, a 5% increase over the third quarter of 2023. Operating income increased 2% to $445.9 million and operating margins were 26.1% in the quarter. Operating cash flow in the quarter was $487.2 million, up 3% versus the prior year, with free cash flow to net income co ...

Financial Data and Key Metrics Changes - AMETEK reported Q2 2024 sales of $1.73 billion, a 5% increase from Q2 2023, with organic sales down 2% and acquisitions contributing 8 points [8][9] - Operating income reached a record $448 million, up 7% year-over-year, with operating margins at 25.8%, an increase of 40 basis points [8][9] - EBITDA was a record $545 million, up 10% from the previous year, with EBITDA margins at 31.4% [8][9] - Earnings per diluted share were $1.66, a 6% increase compared to Q2 2023, exceeding guidance [9] Business Line Data and Key Metrics Changes - **Electronic Instruments Group (EIG)**: Sales were $1.15 billion, a 2% increase, with operating income of $350 million, up 14%, and operating margins at 30.3%, up 320 basis points [9][10] - **Electric Mechanical Group (EMG)**: Sales were a record $81 million, a 14% increase, but organic sales declined 6% due to inventory normalization [10][11] - Acquisitions contributed significantly to both EIG and EMG, with EIG benefiting from aerospace and defense sectors [9][10] Market Data and Key Metrics Changes - North America saw low single-digit declines, while Europe experienced modest growth in Q2 2024 [73] - Asia had low single-digit declines, with China showing a decrease, but excluding China, Asia was flat [73] Company Strategy and Development Direction - AMETEK plans to focus on operational efficiencies and strategic acquisitions to navigate near-term headwinds [7][14] - The company expects to invest an additional $90 million in growth initiatives, particularly in R&D and marketing [14] - The management remains confident in long-term growth despite current market challenges, emphasizing a strong pipeline for acquisitions [14][60] Management's Comments on Operating Environment and Future Outlook - Management noted continued headwinds from inventory destocking and cautious customer behavior, leading to adjusted sales and earnings guidance for the year [7][15] - The company anticipates sales growth of 5% to 7% for the full year, with organic sales expected to be flat to down low single digits [15] - Management expressed confidence in navigating the current environment and achieving long-term results [16] Other Important Information - The effective tax rate for Q2 was 19%, with expectations for a lower rate in Q4 due to statute expirations [18] - Total debt at the end of Q2 was $2.65 billion, down from $3.3 billion at the end of 2023, with significant financial capacity for growth initiatives [19] Q&A Session Summary Question: Changes in customer sentiment and project delays - Management acknowledged that customers are taking longer to approve projects due to macroeconomic factors, including elections and financing issues [31][32] Question: Impact of destocking on Paragon Medical - Paragon Medical is experiencing a similar destocking process, but management remains optimistic about long-term growth once the inventory correction is complete [38] Question: Pricing dynamics and project costs - Management indicated that AMETEK's products are typically a small part of larger projects, and there has been no significant pushback on pricing due to the differentiated technology [62] Question: Outlook for semiconductor business - The semiconductor business showed growth driven by strong demand for next-generation defect detection systems, positioning AMETEK well for future growth [78]

Financial Performance - Consolidated net sales for Q2 2024 were $1,734.8 million, an increase of $88.7 million or 5.4% compared to Q2 2023's $1,646.1 million[89] - Total international sales for Q2 2024 were $790.0 million, representing 45.5% of net sales, a slight increase of $3.7 million or 0.5% from Q2 2023[89] - Orders for Q2 2024 were $1,677.2 million, an increase of $22.8 million or 1.4% compared to Q2 2023, with a backlog of unfilled orders at $3,403.0 million, down 3.7% from December 31, 2023[90] - Segment operating income for Q2 2024 was $473.0 million, an increase of $29.7 million or 6.7% from Q2 2023, with operating margins at 27.3%[91] - Consolidated operating income for Q2 2024 was a record $447.5 million, or 25.8% of net sales, up $28.7 million or 6.9% from Q2 2023[94] - Net income for Q2 2024 was $337.7 million, an increase of $13.5 million or 4.1% compared to Q2 2023's $324.2 million[95] - Diluted earnings per share for Q2 2024 were $1.45, an increase of $0.05 or 3.6% from $1.40 in Q2 2023[95] Tax and Interest - The effective tax rate for Q2 2024 was 19.0%, up from 18.2% in Q2 2023, primarily due to higher U.S. taxes on foreign sourced earnings[95] - Interest expense for Q2 2024 was $30.6 million, an increase of $11.9 million or 63.4% compared to Q2 2023, driven by higher borrowings related to acquisitions[94] Year-to-Date Performance - For the first six months of 2024, net sales were $3,471.0 million, an increase of $227.8 million or 7.0% compared to the same period in 2023[99] - EIG's net sales for the first six months of 2024 reached $2,310.4 million, a 2.6% increase from $2,251.9 million in the same period of 2023, driven by a 2% increase from acquisitions[106] - EIG's operating income increased by 13.9% to $702.8 million for the first six months of 2024, compared to $616.8 million in the first six months of 2023, with operating margins improving to 30.4% from 27.4%[106] - EMG's net sales totaled $1,160.6 million for the first six months of 2024, marking a 17.1% increase from $991.3 million in the same period of 2023, primarily due to a 22% increase from acquisitions[107] - EMG's operating income decreased by 16.7% to $213.8 million for the first six months of 2024, down from $256.7 million in the same period of 2023, with operating margins declining to 18.4% from 25.9%[108] Cash Flow and Dividends - Cash provided by operating activities increased by 9.7% to $791.7 million for the first six months of 2024, compared to $721.8 million in the same period of 2023[109] - Free cash flow for the first six months of 2024 was $742.6 million, up from $673.9 million in the same period of 2023[109] - Cash dividends paid increased to $129.4 million for the first six months of 2024, compared to $115.1 million in the same period of 2023, reflecting a 12% increase in the quarterly cash dividend[113] Debt and Liquidity - Total debt decreased to $2,651.4 million at June 30, 2024, down from $3,313.3 million at December 31, 2023, with a debt-to-capital ratio of 22.3%[111] - Cash and cash equivalents totaled $396.6 million at June 30, 2024, slightly down from $409.8 million at December 31, 2023[114] Strategic Focus - The company is focused on future acquisitions and product development, while maintaining compliance with all financial covenants[116]

[Second Quarter 2024 Financial Results](index=1&type=section&id=AMETEK%20Announces%20Second%20Quarter%20Results) AMETEK reported strong Q2 2024 results, with sales up 5% to $1.73 billion and adjusted diluted EPS of $1.66 [Q2 2024 Consolidated Financial Highlights](index=1&type=section&id=Q2%202024%20Consolidated%20Financial%20Highlights) Consolidated financial highlights for Q2 2024, including sales, operating income, and cash flow Q2 2024 Consolidated Financial Highlights (YoY Change) | Metric | Q2 2024 Value | YoY Change | | :----------------------- | :------------ | :--------- | | Sales | $1.73 billion | +5% | | Operating Income | $447.5 million | +7% | | Operating Margins | 25.8% | +40 bps | | Operating Cash Flow | $381.4 million | +14% | | GAAP Diluted EPS | $1.45 | - | | Adjusted Diluted EPS | $1.66 | +6% | | Free Cash Flow | $360.0 million | +17% | | Free Cash Flow Conversion | 107% | +12% | - AMETEK achieved strong operating performance with outstanding core margin expansion, **record operating income and EBITDA**, and **earnings growth** exceeding expectations, alongside **excellent cash flows**[2](index=2&type=chunk) [Electronic Instruments Group (EIG) Performance](index=1&type=section&id=Electronic%20Instruments%20Group%20(EIG)) EIG delivered strong Q2 2024 performance with increased sales and robust margin expansion EIG Q2 2024 Performance (YoY Change) | Metric | Q2 2024 Value | YoY Change | | :-------------------- | :------------ | :--------- | | Sales | $1.15 billion | +2% | | Operating Income | $349.9 million | +14% | | Operating Income Margins | 30.3% | +320 bps | - EIG delivered strong results with **excellent operating performance**, leading to **outstanding profit growth** and **robust margin expansion**, positioning its businesses well across diverse market segments[3](index=3&type=chunk) [Electromechanical Group (EMG) Performance](index=2&type=section&id=Electromechanical%20Group%20(EMG)) EMG faced inventory normalization headwinds but achieved solid operating performance with sequential margin gains EMG Q2 2024 Performance (YoY Change) | Metric | Q2 2024 Value | YoY Change | | :-------------------- | :------------ | :--------- | | Sales | $581.2 million | +14% | | Operating Income | $123.1 million | - | | Operating Income Margins | 21.2% | - | - EMG experienced headwinds from **inventory normalization** across its OEM customer base but delivered **solid operating performance** with **sequential margins improving 50 basis points** versus the first quarter's adjusted margins[5](index=5&type=chunk) [2024 Business Outlook and Guidance](index=2&type=section&id=2024%20Outlook) AMETEK adjusted full-year 2024 sales and earnings guidance due to inventory normalization and customer caution [Full Year 2024 Guidance](index=2&type=section&id=Full%20Year%202024%20Guidance) AMETEK's updated full-year 2024 guidance reflects anticipated sales and adjusted diluted EPS ranges - The company expects **inventory normalization** within its OEM customer base to continue through the balance of 2024, with **customers becoming more cautious**, leading to some **short-term delays in project spending**[6](index=6&type=chunk) Full Year 2024 Guidance (YoY Change) | Metric | Range | YoY Change | | :-------------------- | :---------------- | :--------- | | Overall Sales | Up 5% to 7% | +5% to +7% | | Adjusted Diluted EPS | $6.70 to $6.80 | +5% to +7% | [Third Quarter 2024 Guidance](index=2&type=section&id=Third%20Quarter%202024%20Guidance) AMETEK's specific guidance for Q3 2024 includes expected sales growth and adjusted diluted EPS Third Quarter 2024 Guidance (YoY Change) | Metric | Range | YoY Change | | :-------------------- | :---------------- | :--------- | | Overall Sales | Up mid-single digits | - | | Adjusted Diluted EPS | $1.60 to $1.62 | -1% to -2% | [Company Information](index=2&type=section&id=About%20AMETEK) Overview of AMETEK as a global industrial technology solutions provider, detailing its growth model and financial objectives [About AMETEK](index=2&type=section&id=About%20AMETEK) AMETEK is a global industrial technology solutions provider, driven by a strategic growth model and financial objectives - AMETEK is a leading global provider of industrial technology solutions, serving diverse niche markets with annual sales of approximately **$7.0 billion**[9](index=9&type=chunk) - The AMETEK Growth Model integrates **Four Growth Strategies**: **Operational Excellence**, **New Product Development**, **Global and Market Expansion**, and **Strategic Acquisitions**, with a disciplined focus on **cash generation** and **capital deployment**[9](index=9&type=chunk)[10](index=10&type=chunk) - AMETEK's objective is **double-digit percentage growth in earnings per share** over the business cycle and a **superior return on total capital**[10](index=10&type=chunk) [Forward-Looking Statements](index=3&type=section&id=Forward-looking%20Information) This section outlines the inherent risks and uncertainties associated with AMETEK's forward-looking statements - Statements regarding future events and financial performance are **forward-looking** and subject to **various factors and uncertainties**, including **risks related to acquisitions, international operations, supply chain disruptions, new product development, raw material prices, government regulations, competition, liquidity, and general economic conditions**[11](index=11&type=chunk) - AMETEK **disclaims any intention or obligation to update or revise** any forward-looking statements[11](index=11&type=chunk) [Investor Relations Contact](index=3&type=section&id=Contact) Contact information for investor inquiries is provided, directing stakeholders to the Vice President of Investor Relations - For investor inquiries, contact **Kevin Coleman, Vice President, Investor Relations and Treasurer**, at kevin.coleman@ametek.com or Phone: 610.889.5247[12](index=12&type=chunk) [Financial Statements and Reconciliations](index=4&type=section&id=Consolidated%20Statement%20of%20Income) AMETEK's unaudited consolidated financial statements, including income, segment information, balance sheet, and GAAP to non-GAAP reconciliations [Consolidated Statement of Income](index=4&type=section&id=Consolidated%20Statement%20of%20Income) AMETEK's unaudited consolidated statement of income details revenues, expenses, and net income for specified periods Consolidated Statement of Income (Unaudited, In thousands, except per share amounts) | Metric | Three Months Ended June 30, 2024 | Three Months Ended June 30, 2023 | Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 | | :---------------------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net sales (in thousands) | $1,734,834 | $1,646,111 | $3,471,014 | $3,243,228 | | Cost of sales (in thousands) | 1,110,425 | 1,053,190 | 2,255,106 | 2,075,715 | | Selling, general and administrative (in thousands) | 176,895 | 174,130 | 351,178 | 343,181 | | Total operating expenses (in thousands) | 1,287,320 | 1,227,320 | 2,606,284 | 2,418,896 | | Operating income (in thousands) | 447,514 | 418,791 | 864,730 | 824,332 | | Interest expense (in thousands) | (30,590) | (18,723) | (65,844) | (39,292) | | Other (expense) income, net (in thousands) | 86 | (3,684) | (547) | (9,057) | | Income before income taxes (in thousands) | 417,010 | 396,384 | 798,339 | 775,983 | | Provision for income taxes (in thousands) | 79,327 | 72,142 | 149,713 | 146,029 | | Net income (in thousands) | $337,683 | $324,242 | $648,626 | $629,954 | | Diluted earnings per share | $1.45 | $1.40 | $2.79 | $2.72 | | Basic earnings per share | $1.46 | $1.41 | $2.80 | $2.74 | | Weighted average common shares outstanding: Diluted shares (in thousands) | 232,304 | 231,261 | 232,170 | 231,245 | | Weighted average common shares outstanding: Basic shares (in thousands) | 231,437 | 230,478 | 231,267 | 230,302 | | Dividends per share | $0.28 | $0.25 | $0.56 | $0.50 | [Information by Business Segment](index=4&type=section&id=Information%20by%20Business%20Segment) AMETEK's net sales and operating income are broken down by Electronic Instruments and Electromechanical segments Information by Business Segment (Unaudited, In thousands) | Metric | Three Months Ended June 30, 2024 | Three Months Ended June 30, 2023 | Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 | | :---------------------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | **Net sales (in thousands):** | | | | | | Electronic Instruments (in thousands) | $1,153,613 | $1,134,646 | $2,310,392 | $2,251,893 | | Electromechanical (in thousands) | 581,221 | 511,465 | 1,160,622 | 991,335 | | Consolidated net sales (in thousands) | $1,734,834 | $1,646,111 | $3,471,014 | $3,243,228 | | **Operating income (in thousands):** | | | | | | Segment operating income: Electronic Instruments (in thousands) | $349,857 | $307,052 | $702,797 | $616,799 | | Segment operating income: Electromechanical (in thousands) | 123,102 | 136,215 | 213,793 | 256,719 | | Total segment operating income (in thousands) | 472,959 | 443,267 | 916,590 | 873,518 | | Corporate administrative expenses (in thousands) | (25,445) | (24,476) | (51,860) | (49,186) | | Consolidated operating income (in thousands) | $447,514 | $418,791 | $864,730 | $824,332 | [Condensed Consolidated Balance Sheet](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheet) AMETEK's condensed consolidated balance sheet details assets, liabilities, and stockholders' equity at specific dates Condensed Consolidated Balance Sheet (In thousands) | Metric | June 30, 2024 (Unaudited, in thousands) | December 31, 2023 (in thousands) | | :----------------------------------------------------------------- | :------------------------ | :------------------ | | **ASSETS** | | | | Current assets: Cash and cash equivalents (in thousands) | $396,573 | $409,804 | | Current assets: Receivables, net (in thousands) | 976,442 | 1,012,932 | | Current assets: Inventories, net (in thousands) | 1,101,719 | 1,132,471 | | Current assets: Other current assets (in thousands) | 292,510 | 269,461 | | Total current assets (in thousands) | 2,767,244 | 2,824,668 | | Property, plant and equipment, net (in thousands) | 861,577 | 891,293 | | Right of use asset, net (in thousands) | 217,469 | 229,723 | | Goodwill (in thousands) | 6,453,513 | 6,447,629 | | Other intangibles, investments and other assets (in thousands) | 4,496,063 | 4,630,220 | | Total assets (in thousands) | $14,795,866 | $15,023,533 | | **LIABILITIES AND STOCKHOLDERS' EQUITY** | | | | Current liabilities: Short-term borrowings and current portion of long-term debt, net (in thousands) | $827,967 | $1,417,915 | | Current liabilities: Accounts payable and accruals (in thousands) | 1,375,080 | 1,464,658 | | Total current liabilities (in thousands) | 2,203,047 | 2,882,573 | | Long-term debt, net (in thousands) | 1,823,410 | 1,895,432 | | Deferred income taxes and other long-term liabilities (in thousands) | 1,517,005 | 1,515,337 | | Stockholders' equity (in thousands) | 9,252,404 | 8,730,191 | | Total liabilities and stockholders' equity (in thousands) | $14,795,866 | $15,023,533 | [Reconciliations of GAAP to Non-GAAP Financial Measures](index=6&type=section&id=Reconciliations%20of%20GAAP%20to%20Non-GAAP%20Financial%20Measures) Reconciliations of GAAP to non-GAAP financial measures, including diluted EPS, cash flow, and forecasted EPS Reconciliation of Diluted EPS (GAAP to Non-GAAP) (In thousands, except per share amounts) | Metric | Three Months Ended June 30, 2024 | Three Months Ended June 30, 2023 | | :-------------------------------------------------------------------------- | :------------------------------- | :------------------------------- | | Diluted earnings per share (GAAP) | $1.45 | $1.40 | | Pretax amortization of acquisition-related intangible assets | 0.27 | 0.22 | | Income tax benefit on amortization of acquisition-related intangible assets | (0.06) | (0.05) | | Adjusted Diluted earnings per share (Non-GAAP) | $1.66 | $1.57 | Reconciliation of Cash Flow (GAAP to Non-GAAP) (In thousands) | Metric | Three Months Ended June 30, 2024 (in thousands) | Three Months Ended June 30, 2023 (in thousands) | | :-------------------------------------------------------------------------- | :------------------------------- | :------------------------------- | | Cash provided by operating activities (GAAP) | $381,435 | $335,247 | | Deduct: Capital expenditures | (21,416) | (27,829) | | Free cash flow (Non-GAAP) | $360,019 | $307,418 | | Free Cash Flow Conversion (Free cash flow divided by net income) | 107% | 95% | Forecasted Diluted EPS (GAAP to Non-GAAP) (In thousands, except per share amounts) | Metric | Three Months Ended September 30, 2024 (Low) | Three Months Ended September 30, 2024 (High) | Year Ended December 31, 2024 (Low) | Year Ended December 31, 2024 (High) | | :-------------------------------------------------------------------------- | :------------------------------------------ | :------------------------------------------- | :--------------------------------- | :--------------------------------- | | Diluted earnings per share (GAAP) | $1.39 | $1.41 | $5.78 | $5.88 | | Paragon integration costs | — | — | 0.13 | 0.13 | | Income tax benefit on Paragon integration costs | — | — | (0.03) | (0.03) | | Pretax amortization of acquisition-related intangible assets | 0.27 | 0.27 | 1.08 | 1.08 | | Income tax benefit on amortization of acquisition-related intangible assets | (0.06) | (0.06) | (0.26) | (0.26) | | Adjusted Diluted earnings per share (Non-GAAP) | $1.60 | $1.62 | $6.70 | $6.80 | [Use of Non-GAAP Financial Information](index=6&type=section&id=Use%20of%20Non-GAAP%20Financial%20Information) The rationale for using non-GAAP financial measures is explained, highlighting their utility for investors - The company supplements GAAP financial statements with non-GAAP information to provide investors with **greater insight, increased transparency**, and a **more comprehensive understanding** of management's financial and operational decision-making[20](index=20&type=chunk) - Non-GAAP measures help investors better understand **long-term profitability trends**, **facilitate comparisons** to prior and future periods, and to peers, when reconciled to comparable GAAP measures[21](index=21&type=chunk)

Table of Contents _________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12981 AMETEK, Inc. (Exact name of ...

AMETEK, Inc. (NYSE:AME) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kevin Coleman - Vice President, Investor Relations and Treasurer Dave Zapico - Chairman of the Board and Chief Executive Officer Dalip Puri - Executive Vice President and Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Jeffrey Sprague - Vertical Research Partners Peter Costa - Mizuho Scott Graham - Seaport Research Partners Andrew Obin - Bank of America Christopher Glynn ...

Financial Performance - AMETEK's Q1 2024 sales reached a record $1.74 billion, representing a 9% increase compared to Q1 2023[1] - Adjusted earnings per diluted share for Q1 2024 were $1.64, up 10% from Q1 2023, while GAAP earnings per diluted share were $1.34[1][2] - The Electronic Instruments Group (EIG) reported sales of $1.16 billion, a 4% increase year-over-year, with operating income margins at a record 30.5%[3] - The Electromechanical Group (EMG) achieved record sales of $579.4 million, up 21% from the previous year, with core operating margins at 24.1%[4] - The company reported a net income of $310.9 million for Q1 2024, compared to $305.7 million in Q1 2023[12] - Adjusted Operating income (Non-GAAP) increased to $446,447 for the three months ended March 31, 2024, compared to $405,541 in the prior year, representing a growth of about 10.1%[16] - Adjusted Diluted earnings per share (Non-GAAP) rose to $1.64, up from $1.49 year-over-year, indicating an increase of approximately 10.1%[16] - The company expects diluted earnings per share (GAAP) for the three months ending June 30, 2024, to be between $1.42 and $1.44[17] - The projected earnings per share for the year ending December 31, 2024, is expected to be between $5.82 and $5.94[17] Cash Flow and Assets - Operating cash flow for Q1 2024 was $410 million, with a free cash flow conversion rate of 123%[2] - AMETEK's total assets as of March 31, 2024, were approximately $14.86 billion, a decrease from $15.02 billion at the end of 2023[14] - Free cash flow (Non-GAAP) for the period was $382,575, compared to $366,530 in the previous year, marking an increase of about 4.4%[16] - Free cash flow conversion (Non-GAAP) improved to 123%, up from 120% year-over-year[16] Future Outlook - AMETEK expects overall sales for 2024 to increase by low double digits compared to 2023, with adjusted earnings per diluted share projected to be between $6.74 and $6.86, reflecting a 6% to 8% increase[5] - For Q2 2024, AMETEK anticipates sales growth in the mid to high single digits, with adjusted earnings expected to be between $1.63 and $1.65 per share, up 4% to 5% year-over-year[6] Strategic Focus - AMETEK's strategic focus includes operational excellence, new product development, global market expansion, and strategic acquisitions to drive double-digit earnings growth[8] Segment Performance - EMG Segment operating income (GAAP) for the three months ended March 31, 2024, was $90,691, down from $120,504 in the same period last year, reflecting a decrease of approximately 24.7%[16] - EMG Segment operating margin (GAAP) decreased to 15.7% from 25.1% in the prior year, a decline of 9.4 percentage points[16] - Adjusted Core Operating income margin (Non-GAAP) was 27.2%, an increase from 25.4% year-over-year, reflecting a growth of 1.8 percentage points[16] Non-GAAP Financial Measures - The company emphasizes the importance of non-GAAP financial measures to provide investors with a clearer understanding of long-term profitability trends and operational decision-making[18]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-K _____________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12981 _____________________ | --- | |------------------------------------ ...

AMETEK, Inc. (NYSE:AME) Q4 2023 Earnings Conference Call February 6, 2024 8:30 AM ET Company Participants Kevin Coleman - Vice President, Investor Relations and Treasurer Dave Zapico - Chairman and Chief Executive Officer Bill Burke - Executive Vice President and Chief Financial Officer Dalip Puri - Senior Vice President, Operational Finance Conference Call Participants Matt Summerville - D.A. Davidson Deane Dray - RBC Capital Markets Allison Poliniak - Wells Fargo Jeffrey Sprague - Vertical Research Partne ...